NextCure, Inc. (NXTC) Misses Q3 EPS by 6c
Tweet
Share
E-mailGet Alerts NXTC Hot Sheet
Join SI Premium – FREE
NextCure, Inc. (NASDAQ: NXTC) reported Q3 EPS of ($0.41), $0.06 worse than the analyst estimate of ($0.35).
For earnings history and earnings-related data on NextCure, Inc. (NXTC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UGI shares spike on reported KKR bid for the company
- Anthropic pre-IPO credit facility to climb past $10B target - Bloomberg
- Prenetics Global (PRE) Tops Q2 EPS by 18c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
